🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MLS101 is being developed as a low dose psilocybin, that can be administere...
Status
Completed
Location
CMAX Clinical Research
Start Date
2024-11-08
Trial ID
NCT06643637
Treatments Being Tested
The purpose of this study is to assess the effects of 5-HT1A receptor block...
Status
Recruiting
Location
Center for Psychedelics and Consciousness Research
Start Date
2026-08-12
Trial ID
NCT07565493
Treatments Being Tested
Approximately 240 eligible adult participants (≥18 years old) who meet Diag...
Status
Active Not Recruiting
Location
University of Alabama Clinical Research Unit
Start Date
2024-03-13
Trial ID
NCT06308653
Treatments Being Tested
Psilocybin, a serotonin receptor agonist in the brain, significantly and qu...
Status
Not Yet Recruiting
Location
GHU Paris Psychiatrie and Neurosciences
Start Date
2025-10-08
Trial ID
NCT07210112
Treatments Being Tested
This study evaluates whether psilocybin therapy helps patients cope with ch...
Status
Active Not Recruiting
Location
University of California San Francisco
Start Date
2023-12-01
Trial ID
NCT05351541
The purpose of this study is to determine whether psilocybin, a hallucinoge...
Status
Active Not Recruiting
Location
Johns Hopkins Center for Psychedelic and Consciousness Research
Start Date
2021-04-14
Trial ID
NCT04620759
Treatments Being Tested
One hundred participants, ages 21 to 65, who meet Diagnostic and Statistica...
Status
Completed
Location
University of California, San Francisco
Start Date
2020-01-23
Trial ID
NCT03866174
Treatments Being Tested
This is an interventional, parallel arm assignment treatment study in indiv...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research
Start Date
2025-02-25
Trial ID
NCT06592833
Treatments Being Tested
Psilocybin, the chemical component of "magic mushrooms", has been administe...
Status
Completed
Location
Centre for Addiction and Mental Health
Start Date
2023-07-01
Trial ID
NCT05710237
Treatments Being Tested
This is a Phase 2, single-center study to explore the efficacy, safety, and...
Status
Active Not Recruiting
Location
Sunstone Medical, PC
Start Date
2023-10-23
Trial ID
NCT05947383
Treatments Being Tested